Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-10

Clinical Trial Update: Personalizing Adoptive Cell Transfer for Solid Tumors: Towards a New Patient-tailored Treatment Option

View source ↗

Summary

The study outlines a personalized adoptive cell transfer approach for solid tumors, including non-small cell lung cancer. It is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ospedale San Raffaele | Conditions: Carcinoma, Non-Small-Cell Lung | Status: NOT_YET_RECRUITING